Abeona Therapeutics Inc (ABEO) - Financial and Strategic SWOT Analysis Review

Abeona Therapeutics Inc (ABEO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Abeona Therapeutics Inc (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc., is a biopharmaceutical company that develops and delivers gene therapy and plasma-based products for severe life-threatening rare diseases. The companys lead programs include ABO-101 and ABO-102 adeno-associated virus. Abeona also develops EB-101 for recessive dystrophic epidermolysis bullosa (RDEB), EB-201 for epidermolysis bullosa (EB), ABO-201 (AAV-CLN3) gene therapy for juvenile Batten disease (JNCL), ABO-202 (AAV-CLN1) gene therapy for treatment of infantile Batten disease (INCL), and ABO-301 (AAV-FANCC) for Fanconi anemia (FA) disorder and ABO-302 for rare blood diseases. The company has partnership with for the commercialization of its products in the US, European Union, Switzerland, Norway, Iceland, Lichtenstein, Australia, New Zealand, China and South Korea. Abeona is headquartered in Dallas, Texas, the US.

Abeona Therapeutics Inc Key Recent Developments

Apr 04,2019 Abeona Therapeutics Receives FDA Fast Track Designation for
Mar 18,2019 Abeona Therapeutics Reports Fourth Quarter and Full Year
Mar 18,2019 Abeona Expands Commercial-Scale Gene and Cell-Therapy Manufacturing at its Cleveland, Ohio Facility in US

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company




Section 1 - About the Company
Abeona Therapeutics Inc - Key Facts
Abeona Therapeutics Inc - Key Employees
Abeona Therapeutics Inc - Key Employee Biographies
Abeona Therapeutics Inc - Major Products and Services
Abeona Therapeutics Inc - History
Abeona Therapeutics Inc - Company Statement
Abeona Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 Company Analysis
Company Overview
Abeona Therapeutics Inc - Business Description
Abeona Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Abeona Therapeutics Inc - Strengths
Abeona Therapeutics Inc - Weaknesses
Abeona Therapeutics Inc - Opportunities
Abeona Therapeutics Inc - Threats
Abeona Therapeutics Inc - Key Competitors
Section 3 Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 Companys Lifesciences Financial Deals and Alliances
Abeona Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Abeona Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Abeona Therapeutics Inc, Recent Deals Summary
Section 5 Companys Recent Developments
Apr 04, 2019: Abeona Therapeutics Receives FDA Fast Track Designation for
Apr 04, 2019: Abeona Therapeutics Receives FDA Fast Track Designation for
Mar 18, 2019: Abeona Therapeutics Reports Fourth Quarter and Full Year
Mar 18, 2019: Abeona Expands Commercial-Scale Gene and Cell-Therapy Manufacturing at its Cleveland, Ohio Facility in US
Feb 11, 2019: Abeona Therapeutics appoints Joao Siffert, M.D. Chief Executive Officer
Jan 31, 2019: Abeona Therapeutics to Present New Supportive Data for Novel Gene Therapies at WORLDSymposium
Jan 08, 2019: Abeona Therapeutics names Christine Silverstein as Chief Financial Officer and Edward Carr as Chief Accounting Officer
Nov 26, 2018: Abeona Therapeutics announces CEO transition
Nov 10, 2018: Abeona Therapeutics reports third quarter 2018 financial results and business highlights
Oct 18, 2018: Abeona Therapeutics names Joao Siffert, M.D. as head of research and development and chief medical officer
Section 6 Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables


Abeona Therapeutics Inc, Key Facts
Abeona Therapeutics Inc, Key Employees
Abeona Therapeutics Inc, Key Employee Biographies
Abeona Therapeutics Inc, Major Products and Services
Abeona Therapeutics Inc, History
Abeona Therapeutics Inc, Subsidiaries
Abeona Therapeutics Inc, Key Competitors
Abeona Therapeutics Inc, Ratios based on current share price
Abeona Therapeutics Inc, Annual Ratios
Abeona Therapeutics Inc, Annual Ratios (Cont...1)
Abeona Therapeutics Inc, Interim Ratios
Abeona Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Abeona Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Abeona Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures


Abeona Therapeutics Inc, Performance Chart (2014 - 2018)
Abeona Therapeutics Inc, Ratio Charts
Abeona Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Abeona Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

Abeona Therapeutics Inc (ABEO) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Abeona Therapeutics Inc (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc., is a biopharmaceutical company that develops and delivers gene therapy and plasma-based products for severe and life-threatening rare diseases. The companys lead

USD 250 View Report

Abeona Therapeutics Inc (ABEO) - Financial and Strategic SWOT Analysis Review

Abeona Therapeutics Inc (ABEO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled

USD 125 View Report

Anika Therapeutics Inc (ANIK) - Product Pipeline Analysis, 2019 Update

Anika Therapeutics Inc (Anika) develops, manufactures, and markets therapeutic products for tissue protection, repair and regeneration. It offers solutions for orthobiologics, dermal, ophthalmic, surgical and veterinary applications. Its major products

USD 750 View Report

Pear Therapeutics Inc - Product Pipeline Analysis, 2019 Update

Pear Therapeutics Inc (Pear Therapeutics) develops software-based prescription digital therapeutics for the treatment of severe medical conditions and diseases. Its product pipeline includes reSET-O for treating opioid use disorder (OUD)

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available